In Vitro Antiamoebic Activity of Cnestis ferruginea and Dianthus basuticus on Entamoeba histolytica Trophozoites
doi.org/10.26538/tjnpr/v5i3.22
Keywords:
Dianthus basuticus, Cnestis ferruginea, Connaraceae, Dianthus, Entamoeba histolytica, AmoebiasisAbstract
Amoebiasis is still a great disease burden in developing countries; this may cause around 100,000 deaths every year worldwide. The appearance of the strains of parasites resistant to conventional drugs used to treat this disease compels the search for new antiparasitic agents. As a result, a growing emphasis has been placed on plants used in traditional medicine to discover new agents with antiparasitic activity. The study determined the antiamoebic activity of Cnestis ferruginea and Dianthus basuticus found in Nigeria and South Africa. The assays were performed on cultures of Entamoeba histolytica growing in the logarithmic phase that were exposed to various concentrations of the ethanol extract of D. basuticus and C. ferruginea plants. The probit of the cultures were calculated, and the IC50 was determined for each extract for antiamoebic activity. The ethanol extract of both C. ferruginea and D. basuticus demonstrated a remarkable in-vitro inhibitory activity against E. histolytica trophozoites. The 50% inhibitory concentrations (IC50) of C. ferruginea and D. basuticus on E. histolytica cultures were 15.07 µg/mL and 12.45 µg/mL, respectively. The results showed that D. basuticus and C. ferruginea have inhibitory activity against Entamoeba histolytica.
References
Troeger C, Forouzanfar M, Rao PC, Khalil I, Brown A, Reiner Jr RC, Fullman N, Thompson RL, Abajobir A, Ahmed M, Alemayohu MA, Alvis-Guzman N, Amare AT, Antonio CA, Asayesh H, Avokpaho E, Awasthi A, Bacha U, Barac A, Betsue BD, Beyene AS, Boneya DJ, Malta DC, Dandona L, Dandona R, Dubey M, Eshrati B, Fitchett JRA, Gebrehiwot TT, Hailu GB, Horino M, Hotez PJ, Jibat T, Jonas JB, Kasaeian A, Kissoon N, Kotloff K, Koyanagi A, Kumar GA, Rai RK, Lal A, Abd El Razek HM, Mengistie MA, Moe C, Patton G, Platts-Mills JA, Qorbani M, Ram U, Roba HS, Sanabria J, Sartorius B, Sawhney M, Shigematsu M, Sreeramareddy C, Swaminathan S, Tedla BA, Jagiellonian RT, Ukwaja K, Werdecker A, Widdowson M,
Yonemoto N, Zaki ME, Lim SS, Naghavi M, Vos T, Hay S, Murray CJL, Mokdad AH. "Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015." Lancet Infect Dis. 2017;
(9):909-948.
Troeger C, Blacker BF, Khalil IA, Rao PC, Cao S, Zimsen SR, Alvis-Guzman N. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018; 18(11):1211-1228.
Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003; 361(9376):2226-2234.
Hawash YA, Ismail KA, Almehmadi M. High Frequency of Enteric Protozoan, Viral, and Bacterial Potential Pathogens in Community Acquired Acute Diarrheal Episodes: Evidence Based on Results of Luminex Gastrointestinal Pathogen Panel Assay. Korean J Parasitol. 2017; 55(5):513-
Carrero JC, Reyes-López M, Serrano-Luna J, Shibayama M, Unzueta J, León-Sicairos N, de la Garza M. Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. Int J Med Microbiol. 2020; 310(1):151358.
Bercu TE, Petri WA, Behm JW. Amebic colitis: new insights into pathogenesis and treatment. Curr Gastroenterol Rep. 2007; 9(5):429-433.
Stanley SL Jr. Amoebiasis. Lancet. 200; 361(9362):1025-1034.
Petri WA Jr. Therapy of intestinal protozoa. Trends Parasitol. 2003; 19(11):523-6
Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010; 1:(50):S16-23.
Upcroft JA, Campbell RW, Benakli K, Upcroft P, Vanelle P. Efficacy of new 5-nitroimidazoles against metronidazolesusceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother. 1999; 43(1):73-76.
Garza-González J, Vargas-Villarreal J, Verde-Star M, Rivas-Morales C, Oranday-Cárdenas A, Hernandez-García M, Garza-Salinas L, González-Salazar F. Antiprotozoal Activity of a Thymus vulgaris Methanol Extract and Its Fractions. Health. 2017; 9:1081-1094.
Nafiu MO and Ashafa AOT. Antioxidant and Inhibitory Effects of Saponin Extracts from Dianthus basuticus Burtt Davy on Key Enzymes Implicated in Type 2 Diabetes In vitro. Pharmacogn Mag. 2017; 13(52):576-582.
Moteetee A and Van-Wyk BE. The medical ethnobotany of Lesotho: a review. Bothalia. 2011; 41(1):209-228.
Olayemi FO, Raji Y, Adegoke OA, Oyeyemi MO. Haematological and some biochemical profiles in male rats treated with Cnestis ferruginea (de Candolle) root extract and its pure fractions. Afr J Pharm Pharmacol. 2013; 7(20):1231-1235.
Ahmed HA. Therapeutic Potentials of Cnestis ferruginea: A Review. J Pharmacogn Phytochem. 2017; 6(6):1397-1401.
Akharaiyi C, Boboye B, Adetuyi FC. Antibacterial, phytochemical and antioxidant properties of Cnestis ferruginea DC (Connaraceae) extracts. J Microbiol Biotech and Food Sci. 2012; 2(2):592-609.
Yakubu MT and Nurudeen QO. Effects of aqueous extract of Cnestis ferruginea (Vahl ex De Cantolle) root on paroxetine-induced sexual dysfunction in male rats. Asian Pac J Reprod. 2012; 1(2):111-116.
Said-Fernández S, Vargas-Villarreal J, Castro-Garza J, Mata-Cárdenas BD, Navarro-Marmolejo L, Lozano-Garza G, Martínez-Rodríguez H. PEHPS medium: an alternative for axenic cultivation of Entamoeba histolytica and E. invadens. Trans R Soc Trop Med Hyg. 1988; 82(2):249- 253.
Mata-Cárdenas BD, Vargas-Villarreal J, González-Salazar F, Palacios-Corona R, Said-Fernández S. A New Vial Microassay to Screen Antiprotozoal Drugs. Pharmacol Online. 2008; 1:529-537.
Okeke IN, Ojo O, Lamikanra A, Kaper JB. Etiology of acute diarrhea in adults in southwestern Nigeria. J Clin Microbiol. 2003; 41(10):4525-4530.
Mbae CK, Nokes DJ, Mulinge E, Nyambura J, Waruru A, Kariuki S. Intestinal parasitic infections in children presenting with diarrhoea in out-patient and in-patient settings in an informal settlement of Nairobi, Kenya. BMC Infect Dis. 2013; 13:243.
Sinniah B, Hassan AKR, Sabaridah I, Soe MM, Ibrahim Z, Ali O. Prevalence of intestinal parasitic infections among communities living in different habitats and its comparison with one hundred and one studies conducted over the past 42 years (1970 to 2013) in Malaysia. Trop Biomed. 2014; 31(2):190-206.
Gonzales MLM, Dans LF, Sio-Aguilar J. Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev. 2019; 1(1):CD006085.
Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P. Involvement of superoxide dismutase and pyruvate:ferredoxin
oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother. 1997; 40(6):833-40.
Wassmann C, Hellberg A, Tannich E, Bruchhaus I. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and
flavin reductase. J Biol Chem. 1999; 274(37):26051-26056.
Leung AKC, Leung AAM, Wong AHC, Sergi CM, Kam JKM. Giardiasis: An Overview. Recent Pat Inflamm Allergy Drug Discov. 2019; 13(2):134-143.
Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. BMC Infect Dis. 2015; 15:307.
Upcroft P and Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 2001; 14(1):150-164.
Batista L, Pérez Jove J, Rosinach M, Gonzalo V, Sainz E, Loras C, Forné M, Esteve M, Fernández-Bañares F. Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review. Gastroenterol Hepatol. 2017; 40(6):381-387.
Adisa RA, Choudhary MI, Adewoye EO, Olorunsogo OO. Hypoglycaemic and biochemical properties of Cnestis ferruginea. Afr J Trad Compl Altern Med. 2010; 7(3):185- 194.
Kazeem MI and Ashafa AOT. In-vitro antioxidant and antidiabetic potentials of Dianthus basuticus Burtt Davy whole plant extract. J Herbal Med. 2015; 5(3):158-164.
Lamula SQN and Ashafa AOT. Antimicrobial and cytotoxic potential of Dianthus basuticus used in Basotho traditional practice Bangladesh. J Pharmacol, 2014; 9:105-111.
Kouakou K, Panda SK, Yang MR, Lu JG, Jiang ZH, Van Puyvelde L, Luyten W. Isolation of Antimicrobial Compounds from Cnestis ferruginea Vahl ex. DC (Connaraceae) Leaves Through Bioassay-Guided Fractionation. Front Microbiol. 2019; 11(10):705.
Ogbede ON, Eguavoen OI, Parvez M. Chemical studies in the anthocyanins of the local plants. J Chem Soc Pak. 1986; 8:545-547.
Rajput SB, Tonge MB, Karuppayil SM. An overview on traditional uses and pharmacological profile of Acorus calamus Linn. (Sweet flag) and other Acorus species. Phytomed. 2014; 21(3):268-276.
Jiménez-Arellanes A, León-Díaz R, Meckes M, Tapia A, Molina-Salinas GM, Luna-Herrera J, Yepez-Mulia M. Antiprotozoal and Antimycobacterial Activities of Pure Compounds from Aristolochia elegans Rhizomes. EvidBased Compl Altern Med. 2012; 2012:1-7.
Calzada F, Cervantes-Martínez JA, Yépez-Mulia L. In vitro antiprotozoal activity from the roots of Geranium mexicanum and its constituents on Entamoeba histolytica and Giardia lamblia. J Ethnopharmacol. 2005; 98(1-2):191-193.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
